Filter
282
Filtered Results: 282
Text search:
D.
Mueller
et
al.
Featured
Recommendations
24
New Publications
35
Language
Document type
No document type
116
Studies & Reports
84
Guidelines
61
Manuals
10
Training Material
5
Strategic & Response Plan
4
Fact sheets
2
Countries / Regions
Global
16
Russia
13
Western and Central Europe
8
South Africa
7
Latin America and the Carribbean
6
Germany
5
Uganda
4
India
4
Eastern Europe and Central Asia
4
Eastern Europe
4
Tanzania
3
Indonesia
3
Ukraine
3
Middle East and North Africa
3
Nigeria
2
Congo, Democratic Republic of
2
Philippines
2
South Sudan
2
Syria
2
Kenya
2
Malawi
2
Mozambique
2
Brazil
2
Yemen
2
West and Central Africa
2
Venezuela
2
Ghana
1
Zimbabwe
1
Haiti
1
Rwanda
1
Sudan
1
Benin
1
Argentina
1
Angola
1
Lesotho
1
Myanmar / Burma
1
East and Southern Africa
1
South–East Asia Region
1
Paraguay
1
Africa
1
Vietnam
1
Japan
1
France
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
65
Clinical Guidelines
17
Public Health
10
Women & Child Health
8
Pharmacy & Technologies
7
Key Resources
6
Capacity Building
1
Toolboxes
COVID-19
52
Mental Health
27
Planetary Health
24
HIV
21
AMR
15
Disability
14
Health Financing Toolbox
13
NTDs
12
TB
11
NCDs
7
Rapid Response
6
Caregiver
6
Pharmacy
5
Global Health Education
4
Ebola
2
Cholera
2
Natural Hazards
2
Refugee
2
Social Ethics
2
Specific Hazards
1
Health Financing
1
Recent systematic reviews and meta-analysis of the impact of chemical-based mollusciciding (King et al., 2015, Sokolow et ...., 2016) have concluded that regular mollusciciding is likely to contribute significantly towards elimination of schistosomiasis in high-risk areas. The WHO roadmap’s new focus on “transmission control, wherever possible” (WHO, 2012a) reinforces the need to promote intermediate-host snail control to prevent schistosomiasis transmission.
This operational manual is intended to facilitate the reintroduction of practices and protocols for use of molluscicides in the field in schistosomiasis control programmes. It is complemented by guidelines on the laboratory and field testing of the efficacy of molluscicides for schistosomiasis control (WHO, 2017 [in preparation]).
This operational manual is intended to facilitate the reintroduction of practices and protocols for use of molluscicides in the field in schistosomiasis control programmes. It is complemented by guidelines on the laboratory and field testing of the efficacy of molluscicides for schistosomiasis control (WHO, 2017 [in preparation]).
Vreeman RC et al. Journal of the International AIDS Society 2017, 20(Suppl 3):21497 http://www.jiasociety.org/index.php/jias/article/view/21497 | http://dx.doi.org/10.7448/IAS.20.4.21497
Review Article
Granich et al. Int J Virol AIDS 2018, 5:043 DOI: 10.23937/2469-567X/1510043 Volume 5 | Issue 1
Cet ouvrage est l’adaptation en langue française d’un des livres les plus demandés de l’OMS: Surgical Care at the District Hospital. Il y a longtemps qu’il était attendu notamment par l’Afrique francophone. En effet l’ambition de ce l...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
En 2015, 5,9 millions d'enfants de moins de cinq ans sont décédés (1). Les principales causes de mortalité infantile dans le monde sont la pneumonie, la prématurité, les complications durant l'accouchement, la septicémie néonatale, l...
L'OMS a développé une définition de cas clinique de l'état post COVID-19 par la méthodologie Delphi qui comprend 12 domaines, disponible pour une utilisation dans tous les contextes. Cette première version a été élaborée par des patients, des chercheurs ... d'autres personnes, représentant toutes les Régions de l'OMS, étant entendu que la définition peut changer à mesure que de nouvelles preuves apparaissent et que notre compréhension des conséquences de la COVID-19 continue d'évoluer.
L'état post COVID-19 survient chez les personnes ayant des antécédents d'infection probable ou confirmée par le CoV-2 du SRAS, généralement 3 mois après l'apparition de symptômes qui durent au moins 2 mois et ne peuvent être expliqués par un autre diagnostic. Les symptômes courants comprennent la fatigue, l'essoufflement, le dysfonctionnement cognitif mais aussi d'autres et ont généralement un impact sur le fonctionnement quotidien. Les symptômes peuvent être d'apparition récente après le rétablissement initial d'un épisode aigu de COVID-19 ou persister depuis la maladie initiale. Les symptômes peuvent également fluctuer ou rechuter au fil du temps.
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
Health Evidence Network Synthesis Report, No. 47
The increasing number of refugees, asylum seekers and irregular migrants poses a challenge for mental health services in Europe. This review found that these groups are exposed to risk factors for mental disorders before, during and after migration. ...
Los módulos que conforman el paquete técnico HEARTS están dirigidos a los formuladores de políticas públicas y gerentes, directores o coordinadores de programas a diferentes niveles dentro de los ministerios de salud cuyo trabajo influye sobre la prestación de servicios de salud a nivel prima...
Desde hace muchas décadas, los microbios, en particular las bacterias, se han vuelto cada vez más resistentes a diversos antimicrobianos. El aval de la Asamblea Mundial de la Salud al Plan de Acción Mundial sobre la resistencia a los antimicrobia...
La collaboration avec les autorités nationales de gestion des catastrophes
Stewardship is defined as “the careful and responsible management of something entrusted to one’s care”. It was originally applied in the health-care setting as a tool for optimizing antimicrobial use, termed “antimicrobial stewardship” (AMS). Stewardship has since be...
Front. Hum. Neurosci., 25 September 2009 | https://doi.org/10.3389/neuro.09.026.2009
Eau, assainissement, hygiène et gestion des déchets en rapport avec le virus responsable de la COVID-19
recommended
orientations provisoires, 23 avril 2020
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
A thesis submitted for the Degree of Master of Theology at the South African Theological Seminary
